Stevanato Group

STVN Mid Cap

Healthcare · Medical Instruments & Supplies

Updated: Apr 5, 2026, 17:43 UTC

$13.73

-0.15% today

52W: $12.89 – $28.00

52W Low: $12.89 Position: 5.6% 52W High: $28.00

🔗 Compare Brokers

Key Metrics

P/E Ratio

23.27x

Price-to-Earnings

Forward P/E

16.07x

Forward Price/Earnings

P/S Ratio

3.16x

Price-to-Sales

EV/EBITDA

14.41x

Enterprise Value/EBITDA

Div. Yield

46%

Annual dividend yield

Market Cap

$3.7B

Market Capitalization

Revenue Growth

4.8%

YoY Revenue Growth

Profit Margin

11.79%

Net profit margin

ROE

9.67%

Return on Equity

Beta

0.62

Market sensitivity

Short Interest

3.08%

% of float sold short

Avg. Volume

708,768

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

9 analysts

Avg. Price Target

$25.17

+83.3% upside

Target Range

$17.50 – $32.00

About the Company

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales servic

Sector: Healthcare Industry: Medical Instruments & Supplies Country: Italy Employees: 6,010 Exchange: NYQ